Chlorhexidine gluconate baths can help reduce MRSA by up to 55%, study shows

Bathing daily with with chlorhexidine gluconate can reduce incidence of some hospital-acquired infections, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus, according to a study published in the American Journal of Infection Control.

Researchers conducted the study in four inpatient units in a Canadian hospital from May 1, 2014, to August 10, 2015. The units were divided into intervention and control groups. Patients in the intervention units were told to bathe everyday with CGH over a seven-month period, while those in the control unit were asked to bathe with non-medicated soap and water.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox

Here are four insights:

1. Fifty-eight percent of patients in the intervention units complied with the daily CGH bathing instructions.

2. Hospital-associated MRSA decreased by 55 percent for the intervention cohort as compared to the control cohort.

3. Hospital-associated VRE decreased by 36 percent for intervention units compared with the control group.

4. There was no significant difference in rates of hospital-associated Clostridium difficile.

More articles on healthcare quality:
Hospital room decontamination: 5 questions with an infection prevention expert
Researchers discover new way to prohibit bacteria growth on medical devices
Study: Preoperative opioid use a strong predictor of prolonged post-surgery drug refills

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Content

Featured Webinars

Featured Whitepapers